Physician profile
Ronald B Kuppersmith
NPI 1013959287
$325,092.31
in general payments reported to CMS, 2019-2025
8 companies · $91K in 2025
The $91K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $15.64 · 2021: $100 · 2022: $43K · 2023: $90K · 2024: $100K · 2025: $91K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $225K · Travel and Lodging: $51K · Food and Beverage: $4,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $225,496.00 |
| Travel and Lodging | $51,376.49 |
| Food and Beverage | $4,084.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $322,924.08 | 2022-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Stryker Corporation | $1,243.85 | 2019-2025 | Na, Scopis Ent, Clarifix |
| Acclarent, INC | $505.93 | 2021-2022 | |
| Aerin Medical INC. | $199.32 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $92.70 | 2025 | Dupixent |
| Olympus America INC. | $61.80 | 2019-2020 | |
| Integra Lifesciences Corporation | $34.49 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Inspire Medical Systems, INC. | $30.14 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Kuppersmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.